The cytokine-mediated suppression of ADAMTS13 activity results in VWF imbalances, which lead to microvascular thrombosis and unfavorable clinical outcomes, particularly in patients with disseminated intravascular coagulation [31,32]. Here, ADAMTS13 is linked to Venous thrombosis.